4.7 Article

Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model

期刊

SCIENTIFIC REPORTS
卷 11, 期 1, 页码 -

出版社

NATURE RESEARCH
DOI: 10.1038/s41598-021-85412-1

关键词

-

资金

  1. National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2019R1A2C1088965]
  2. Korea Environment Industry & Technology Institute (KEITI) through the Technology Development Project for Safety Management of Household Chemical Products - Korean Ministry of Environment (MOE) [2020002960007, NTIS-1485017184]
  3. Li Ka Shing foundation [LD030302]

向作者/读者索取更多资源

Demyelination causes neuron loss leading to compromised locomotor function and underlying diseases like multiple sclerosis, with potential treatment options like tacrine and duloxetine showing promise for remyelination. Zebrafish models offer easier testing of promotive compounds compared to mammalian models, presenting novel avenues for research and potential therapeutic interventions.
Demyelination leads to a loss of neurons, which results in, among other consequences, a severe reduction in locomotor function, and underlies several diseases in humans including multiple sclerosis and polyneuropathies. Considerable clinical progress has been made in counteracting demyelination. However, there remains a need for novel methods that reduce demyelination while concomitantly achieving remyelination, thus complementing the currently available tools to ameliorate demyelinating diseases. In this study, we used an established zebrafish demyelination model to test selected compounds, following a screening in cell culture experiments and in a mouse model of spinal cord injury that was aimed at identifying beneficial functions of the neural cell adhesion molecule L1. In comparison to mammalian nervous system disease models, the zebrafish allows testing of potentially promotive compounds more easily than what is possible in mammals. We found that our selected compounds tacrine and duloxetine significantly improved remyelination in the peripheral and central nervous system of transgenic zebrafish following pharmacologically induced demyelination. Given that both molecules are known to positively affect functions other than those related to L1 and in other disease contexts, we propose that their combined beneficial function raises hope for the use of these compounds in clinical settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据